In summary, MSLN drives the progression of malignant tumors through multiple mechanisms, including regulating epithelial-mesenchymal transition, inducing chemotherapy resistance, and remodeling the tumor microenvironment (Figure 3). Here, MSLN is linked to neoplasm.